Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ablative Radiation Therapy to Restrain Everything Safely Treatable (ARREST): A Phase 1 Study of Stereotactic Ablative Radiation Therapy for Polymetastatic Disease.
Nguyen TK, Ramadan S, Palma DA, Corkum MT, O' Neil M, Celinski A, Fakir H, Warner A, Hallock A, Correa RJM, Qu XM, Lock M, Lang P, Velker V, Bauman GS. Nguyen TK, et al. Among authors: velker v. Int J Radiat Oncol Biol Phys. 2024 Dec 1;120(5):1231-1238. doi: 10.1016/j.ijrobp.2024.06.033. Epub 2024 Jul 9. Int J Radiat Oncol Biol Phys. 2024. PMID: 38986914 Clinical Trial.
Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE Trial.
Mendez LC, Crook J, Martell K, Schaly B, Hoover DA, Dhar A, Velker V, Ahmad B, Lock M, Halperin R, Warner A, Bauman GS, D'Souza DP. Mendez LC, et al. Among authors: velker v. Int J Radiat Oncol Biol Phys. 2024 Jul 1;119(3):803-812. doi: 10.1016/j.ijrobp.2023.11.058. Epub 2023 Dec 8. Int J Radiat Oncol Biol Phys. 2024. PMID: 38072323 Clinical Trial.
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial.
Movsas B, Rodgers JP, Elshaikh MA, Martinez AA, Morton GC, Krauss DJ, Yan D, Citrin DE, Hershatter BW, Michalski JM, Ellis RJ, Kavadi VS, Gore EM, Gustafson GS, Schulz CA, Velker VM, Olson AC, Cury FL, Papagikos MA, Karrison TG, Sandler HM, Bruner DW. Movsas B, et al. Among authors: velker vm. J Clin Oncol. 2023 Jun 10;41(17):3217-3224. doi: 10.1200/JCO.22.02389. Epub 2023 Apr 27. J Clin Oncol. 2023. PMID: 37104723 Free PMC article. Clinical Trial.
The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).
Mendez LC, Dhar A, Laidley D, Moussa M, Gomez JA, Chin J, Lee TY, Thiessen JD, Hoover D, Surrey K, Helou J, Velker V, Correa RJ, D'Souza D, Bayani J, Bauman G. Mendez LC, et al. Among authors: velker v. BMC Cancer. 2023 Apr 20;23(1):362. doi: 10.1186/s12885-023-10851-0. BMC Cancer. 2023. PMID: 37081426 Free PMC article. Clinical Trial.
Validation of a surface-based deformable MRI-3D ultrasound image registration algorithm toward clinical implementation for interstitial prostate brachytherapy.
Orlando N, Edirisinghe C, Gyacskov I, Vickress J, Sachdeva R, Gomez JA, D'Souza D, Velker V, Mendez LC, Bauman G, Fenster A, Hoover DA. Orlando N, et al. Among authors: velker v. Brachytherapy. 2023 Mar-Apr;22(2):199-209. doi: 10.1016/j.brachy.2022.11.011. Epub 2023 Jan 12. Brachytherapy. 2023. PMID: 36641305
Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis.
Tang T, Gulstene S, McArthur E, Warner A, Boldt G, Velker V, D'Souza D, Bauman G, Mendez LC. Tang T, et al. Among authors: velker v. Clin Transl Radiat Oncol. 2022 Oct 29;38:21-27. doi: 10.1016/j.ctro.2022.10.010. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36353652 Free PMC article.
35 results